🇺🇸 FDA
Patent

US 12156883

Bisphosphocin gel formulations and uses thereof

granted A61KA61K31/7072A61K47/10

Quick answer

US patent 12156883 (Bisphosphocin gel formulations and uses thereof) held by Lakewood Amedex, Inc. expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lakewood Amedex, Inc.
Grant date
Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/7072, A61K47/10, A61K47/34, A61K9/0014